Hasegawa, Naoki

J-GLOBAL         Last updated: May 29, 2019 at 03:38
 
Avatar
Name
Hasegawa, Naoki
E-mail
hasegawnsc.itc.keio.ac.jp
Affiliation
Keio University
Section
School of Medicine Department of Infectious Diseases
Job title
Professor
Degree
モルモットエンドトキシン急性肺損傷における血漿ミエロペルオキシダーゼ測定の意義(KEIO University)
Research funding number
20198724

Research Areas

 
 

Academic & Professional Experience

 
Apr 1985
 - 
Mar 1987
研修医, 慶應義塾大学医学部内科
 
Apr 1987
 - 
Apr 1989
内科医員, 横浜市立市民病院
 
May 1989
 - 
Sep 1994
専修医, 呼吸器内科, 慶應義塾大学医学部
 
Oct 1994
 - 
Mar 1997
内科医長, 国立療養所南横浜病院
 
Apr 1997
 - 
Apr 2000
研究検査科長(兼任), 国立療養所南横浜病院
 

Education

 
Mar 1985
   
 
医学部, 慶應義塾大学 
 

Published Papers

 
Nishimura, T., Ota, M., Mori, M., Fujiwara, H., Takano, Y., Kato, S., Kawabe, H. and Hasegawa, N.
J Infect Chemother      Sep 2018
It is important to evaluate the risk of tuberculosis (TB) infection among health care workers (HCWs) and nursing students in Japan to propose the optimal countermeasure against new TB infection for them. To estimate the annual incidence of TB infe...
Griffith, D. E., Eagle, G., Thomson, R., Aksamit, T. R., Hasegawa, N., Morimoto, K., Addrizzo-Harris, D. J., O'Donnell, A. E., Marras, T. K., Flume, P. A., Loebinger, M. R., Morgan, L., Codecasa, L. R., Hill, A. T., Ruoss, S. J., Yim, J. J., Ringshausen, F. C., Field, S. K., Philley, J. V., Wallace, R. J., van Ingen, J., Coulter, C., Nezamis, J., Winthrop, K. L. and Group, CONVERT Study
Am J Respir Crit Care Med      Sep 2018
Rationale Improved therapeutic options are needed for patients with treatment-refractory nontuberculous mycobacterial lung disease caused by Mycobacterium avium complex (MAC). Objectives To evaluate the efficacy and safety of daily amikacin liposo...
Asakura, T., Ishii, M., Namkoong, H., Suzuki, S., Kagawa, S., Yagi, K., Komiya, T., Hashimoto, T., Okamori, S., Kamata, H., Tasaka, S., Kihara, A., Hegab, A. E., Hasegawa, N. and Betsuyaku, T.
Mucosal Immunol      Aug 2018
Sphingolipids play a pivotal role in the pathogenesis of chronic obstructive pulmonary disease (COPD). However, little is known about the precise roles of sphingosine-1-phosphate (S1P), a bioactive sphingolipid metabolite, and its receptor modulat...
Yagi, K., Asakura, T., Namkoong, H., Suzuki, S., Asami, T., Okamori, S., Kusumoto, T., Funatsu, Y., Kamata, H., Nishimura, T., Ishii, M., Betsuyaku, T. and Hasegawa, N.
BMC Pulm Med   18(1) 114   Jul 2018
Pulmonary Mycobacterium avium complex (pMAC) disease is a chronic, slowly progressive disease. The aim of the present study was to determine the association of six-minute walk test (6MWT) parameters with pulmonary function and the health-related q...
Kubota, H., Uwamino, Y., Matsui, M., Sekizuka, T., Suzuki, Y., Okuno, R., Uchitani, Y., Ariyoshi, T., Aoki, W., Suzuki, S., Kuroda, M., Shinkai, T., Yokoyama, K., Sadamasu, K., Funakoshi, T., Murata, M., Hasegawa, N. and Iwata, S.
J Antimicrob Chemother      Jul 2018
A carbapenem-resistant Enterobacter cloacae complex isolated in Tokyo, Japan, produced a carbapenemase that was detected by a Carba NP test and a modified carbapenem inactivation method, but none of the 'Big Five' carbapenemase genes was detected ...

Conference Activities & Talks

 
肺非定型抗酸菌症(MAC)症の治療例における血清KL-6およびSPD値の経時的変化
YAMAGUCHI KAZUHIRO
第44回日本呼吸器学会総会   Mar 2004   
エンドトキシン(LPS)気道内注入肺損傷モデルにおけるTNF-α Converting Enzyme(TACE)阻害薬の効果
YAMAGUCHI KAZUHIRO
第44回日本呼吸器学会総会   Mar 2004   
日本人軽症喘息患者におけるロイコトリエン受容体拮抗薬反応性規定因子の解析
YAMAGUCHI KAZUHIRO
第44回日本呼吸器学会総会   Mar 2004   
エンドトキシン(LPS)投与マウス肺損傷モデルにおける抗VEGF抗体投与の効果
YAMAGUCHI KAZUHIRO
第44回日本呼吸器学会総会   Mar 2004   
エンドトキシン気道内投与のシグナル伝達に対する抗CD14抗体とtoll-like receptor4遺伝子変異の影響
YAMAGUCHI KAZUHIRO
第44回日本呼吸器学会総会   Mar 2004   

Research Grants & Projects

 
miRNAを介した肺MAC症の病態解明
MEXT,JSPS: Grant-in-Aid for Scientific Research
Project Year: Apr 2016 - Mar 2019    Investigator(s): 長谷川 直樹